Skip to main content

Table 1 Currently available treatments for human trypanosomiasis

From: Trypanosomiasis vector control in Africa and Latin America

 

Date of

introduction

Days of treatment

Likelihood of

serious side

effects

  

T. cruzi

gambiense

rhodesiense

 
  

early

late

early

late

early

late

 

Suramine

1916

-

-

-

-

40a

-

++

Pentamidine

1940

-

-

7

-

-

-

+/-

Melarsoprol

1949

-

-

-

10–30b

-

10–30b

+++++

Nifurtimox

1967

30–60

-

-

15–30c

-

-

++

Benznidazole

1972

30–60

-

-

-

-

-

++

Eflornithine

1990

-

-

-

7–14d

-

-

++

  1. a Suramine: 1 injection per week for 5 weeks
  2. b Melarsoprol: new regime being developed of 1 daily injection for 10 days
  3. c Nifurtimox: not yet registered for use against gambiense, but is being used on compassionate grounds when other treatments fail
  4. d Eflornithine: 4 intravenous perfusions per day